Authors:
MAVROMOUSTAKOS T
ZERVOU M
PANAGIOTOPOULOS D
THEODOROPOULOU E
MATSOUKAS J
KARUSSIS D
Citation: T. Mavromoustakos et al., STRUCTURAL ELUCIDATION AND CONFORMATIONAL PROPERTIES OF THE IMMUNOMODULATOR LINOMIDE, Journal of pharmaceutical and biomedical analysis, 16(5), 1998, pp. 741-751
Authors:
KARUSSIS D
LEKER RR
ASHKENAZI A
ABRAMSKY O
Citation: D. Karussis et al., A SUBGROUP OF MULTIPLE-SCLEROSIS PATIENTS WITH ANTICARDIOLIPIN ANTIBODIES AND UNUSUAL CLINICAL MANIFESTATIONS - DO THEY REPRESENT A NEW NOSOLOGICAL ENTITY, Annals of neurology, 44(4), 1998, pp. 629-634
Authors:
KARPATI T
KARUSSIS D
ABRAMSKY O
MIZRAHIKOLL R
ARBELL I
OVADIA H
Citation: T. Karpati et al., INHIBITION OF EXPERIMENTAL AUTOIMMUNE NEURITIS BY THE IMMUNOMODULATORLINOMIDE, Immunology letters, 63(3), 1998, pp. 141-145
Authors:
KARUSSIS D
VOURKAKARUSSIS U
MIZRACHIKOLL R
ABRAMSKY O
Citation: D. Karussis et al., ACUTE RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) - INDUCTION OF LONG-TERM ANTIGEN-SPECIFIC TOLERANCE WITH BONE-MARROW TRANSPLANTATION/, Neurology, 50(4), 1998, pp. 63004-63004
Authors:
BRAUTBAR C
KWON OJ
KARNI A
AMAR A
MEINER Z
ABRAMSKY O
KARUSSIS D
ISRAEL S
Citation: C. Brautbar et al., HLA CLASS-II SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS AMONG ASHKENAZI ANDNON-ASHKENAZI JEWS, Human immunology, 55, 1997, pp. 50-50
Authors:
WEIDENFELD J
KARUSSIS D
ABRAMSKY O
LEHMANN D
ARBELL I
OVADIA H
Citation: J. Weidenfeld et al., LINOMIDE ACTIVATES THE ADRENOCORTICAL AXIS IN THE RAT - INHIBITION OFEXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY LINOMIDE IS NOT RELATED TO THE INCREASE OF CORTICOSTERONE, Journal of neuroimmunology, 79(1), 1997, pp. 49-53
Authors:
LEHMANN D
KARUSSIS D
MIZRACHIKOLL R
LINDE AS
ABRAMSKY O
Citation: D. Lehmann et al., INHIBITION OF THE PROGRESSION OF MULTIPLE-SCLEROSIS BY LINOMIDE IS ASSOCIATED WITH UP-REGULATION OF CD4(+) CD45RA(+) CELLS AND DOWN-REGULATION OF CD4(+)/CD45RO(+) CELLS/, Clinical immunology and immunopathology, 85(2), 1997, pp. 202-209
Citation: R. Mizrachikoll et al., SYNERGISTIC IN-VIVO EFFECTS OF COP-1 AND INTERFERON-B ON HYPERACUTE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE), Neurology, 48(3), 1997, pp. 6072-6072
Authors:
ARBEL I
KARUSSIS D
MIZRACHIKOLL R
KARPATI T
ABRAMSKY O
Citation: I. Arbel et al., MECHANISMS OF ACTION OF LINOMIDE ON EAE - LINOMIDE INDUCES APOPTOTIC DEATH OF LYMPHOCYTES AND THYMIC ATROPHY, Neurology, 48(3), 1997, pp. 6075-6075
Authors:
KARUSSIS D
ASHKENAZI A
LEKER R
ABRAMSKY O
Citation: D. Karussis et al., PRIMARY ANTIPHOSPHOLIPID SYNDROME MIMICKING - CLINICALLY AND RADIOLOGICALLY - MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 6081-6081
Authors:
KARNI A
KWON OJ
BRAUTBAR C
MEINER Z
ABRAMSKY O
KARUSSIS D
Citation: A. Karni et al., HLA CLASS II-ENCODED GENETIC SUSCEPTIBILITY TO THE DISEASE AND CLINICAL COURSES OF MULTIPLE-SCLEROSIS AMONG ASHKENAZI AND NON ASHKENAZI JEWS, Neurology, 48(3), 1997, pp. 6082-6082
Authors:
KARPATI T
OVADIA H
KARUSSIS D
MIZRACHIKOLL R
LEHMANN D
ABRAMSKY O
Citation: T. Karpati et al., SUPPRESSION OF EXPERIMENTAL ALLERGIC NEURITIS (EAN) WITH LINOMIDE (QUINOLONE-3-CARBOXAMIDE), Neurology, 48(3), 1997, pp. 15002-15002
Authors:
KARUSSIS D
LEHMANN D
OVADIA H
MIZRACHIKOLL R
GJORSTUP P
LINDE A
ASTROM M
ABRAMSKY O
Citation: D. Karussis et al., IMMUNOLOGICAL EVALUATION IN PATIENTS WITH SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS TREATED WITH LINOMIDE, Neurology, 46(2), 1996, pp. 3088-3088
Authors:
LEHMANN D
KARUSSIS D
MIZRACHIKOLL R
ABRAMSKY O
Citation: D. Lehmann et al., IMMUNOMODULATING EFFECTS OF LINOMIDE ON EAE - MECHANISMS OF DOWN-REGULATION OF THE ANTIGEN PRESENTATION PROCESS, Neurology, 46(2), 1996, pp. 16003-16003
Authors:
VOURKAKARUSSIS U
KARUSSIS D
ACKERSTEIN A
SLAVIN S
Citation: U. Vourkakarussis et al., ENHANCEMENT OF GVL EFFECT WITH RHIL-2 FOLLOWING BMT IN A MURINE MODELFOR ACUTE MYELOID-LEUKEMIA IN SJL J MICE/, Experimental hematology, 23(3), 1995, pp. 196-201
Authors:
KARUSSIS D
MEINER Z
LEHMANN D
SCHWARZ A
GOMORI M
OVADIA H
MIZRACHIKOLL R
GJORSTUP P
LINDE A
ABRAMSKY O
Citation: D. Karussis et al., TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS WITH THE IMMUNOMODULATOR LINOMIDE - RESULTS OF A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY WITH MONTHLY MRI EVALUATION, Neurology, 45(4), 1995, pp. 417-417
Authors:
LEHMANN D
KARUSSIS D
MISRACHIKOLL R
SHEZEN E
OVADIA H
ABRAMSKY O
Citation: D. Lehmann et al., ORAL-ADMINISTRATION OF THE OXIDANT-SCAVENGER N-ACETYL-L-CYSTEINE INHIBITS ACUTE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Journal of neuroimmunology, 50(1), 1994, pp. 35-42
Authors:
KARUSSIS D
LEHMANN D
OVADIA H
KALLAND T
MIZRACHIKOLL R
SLAVIN S
ABRAMSKY O
Citation: D. Karussis et al., IMMUNOMODULATION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS WITH LINOMIDE, IN THE ABSENCE OF SYSTEMIC IMMUNOSUPPRESSION, Journal of neurochemistry, 63, 1994, pp. 190000009-190000009